News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
818,218 Results
Type
Article (78133)
Company Profile (813)
Press Release (739259)
Multimedia
Podcasts (173)
Webinars (27)
Section
Business (222795)
Career Advice (3099)
Deals (37962)
Drug Delivery (140)
Drug Development (88604)
Employer Resources (178)
FDA (17717)
Job Trends (16853)
News (378476)
Policy (36829)
Tag
Academia (3001)
Academic (2)
Accelerated approval (23)
Adcomms (34)
Allergies (134)
Alliances (55413)
ALS (162)
Alzheimer's disease (1745)
Antibody-drug conjugate (ADC) (294)
Approvals (17810)
Artificial intelligence (530)
Autoimmune disease (120)
Automation (32)
Bankruptcy (364)
Best Places to Work (12614)
BIOSECURE Act (22)
Biosimilars (180)
Biotechnology (481)
Bladder cancer (147)
Brain cancer (59)
Breast cancer (563)
Cancer (4463)
Cardiovascular disease (398)
Career advice (2619)
Career pathing (39)
CAR-T (270)
CDC (56)
Cell therapy (729)
Cervical cancer (35)
Clinical research (73994)
Collaboration (1551)
Company closure (5)
Compensation (1033)
Complete response letters (61)
COVID-19 (2943)
CRISPR (91)
C-suite (716)
Cystic fibrosis (145)
Data (5509)
Decentralized trials (2)
Denatured (59)
Depression (126)
Diabetes (477)
Diagnostics (7112)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (244)
Drug pricing (202)
Drug shortages (36)
Duchenne muscular dystrophy (217)
Earnings (93739)
Editorial (58)
Employer branding (22)
Employer resources (158)
Events (130485)
Executive appointments (1008)
FDA (20484)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1396)
Gene editing (197)
Generative AI (50)
Gene therapy (588)
GLP-1 (1059)
Government (5231)
Grass and pollen (8)
Guidances (379)
Healthcare (20862)
HIV (52)
Huntington's disease (43)
IgA nephropathy (79)
Immunology and inflammation (264)
Immuno-oncology (30)
Indications (69)
Infectious disease (3204)
Inflammatory bowel disease (195)
Inflation Reduction Act (16)
Influenza (109)
Intellectual property (210)
Interviews (560)
IPO (17556)
IRA (59)
Job creations (4665)
Job search strategy (2203)
Kidney cancer (16)
Labor market (78)
Layoffs (630)
Leadership (36)
Legal (8953)
Liver cancer (94)
Longevity (13)
Lung cancer (628)
Lymphoma (325)
Machine learning (36)
Management (61)
Manufacturing (702)
MASH (164)
Medical device (14833)
Medtech (14871)
Mergers & acquisitions (21405)
Metabolic disorders (1245)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (308)
Neuropsychiatric disorders (79)
Neuroscience (2901)
NextGen: Class of 2025 (7598)
Non-profit (5083)
Now hiring (59)
Obesity (592)
Opinion (319)
Ovarian cancer (149)
Pain (181)
Pancreatic cancer (194)
Parkinson's disease (261)
Partnered (32)
Patents (454)
Patient recruitment (380)
Peanut (58)
People (64529)
Pharmaceutical (144)
Pharmacy benefit managers (30)
Phase I (22920)
Phase II (32196)
Phase III (24288)
Pipeline (3612)
Policy (308)
Postmarket research (3271)
Preclinical (10363)
Press Release (72)
Prostate cancer (224)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (759)
Real estate (7124)
Recruiting (75)
Regulatory (26681)
Reports (43)
Research institute (2701)
Resumes & cover letters (473)
Rett syndrome (22)
RNA editing (15)
RSV (80)
Schizophrenia (145)
Series A (227)
Series B (174)
Service/supplier (29)
Sickle cell disease (90)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (44)
Startups (4113)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (112)
Vaccines (1064)
Venture capital (76)
Weight loss (414)
Women's health (71)
Worklife (20)
Date
Last 7 days (611)
Last 30 days (2626)
Last 365 days (32602)
2025 (31001)
2024 (37843)
2023 (42487)
2022 (53867)
2021 (58634)
2020 (57539)
2019 (51179)
2018 (38913)
2017 (36048)
2016 (36485)
2015 (42690)
2014 (37184)
2013 (34396)
2012 (34877)
2011 (34906)
2010 (34258)
Location
Africa (1121)
Alabama (83)
Alaska (7)
Arizona (288)
Arkansas (14)
Asia (48767)
Australia (8551)
California (10595)
Canada (3109)
China (1004)
Colorado (447)
Connecticut (473)
Delaware (314)
Europe (111465)
Florida (1557)
Georgia (342)
Hawaii (3)
Idaho (65)
Illinois (862)
India (59)
Indiana (510)
Iowa (21)
Japan (363)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1386)
Massachusetts (7860)
Michigan (328)
Minnesota (612)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (116)
New Hampshire (81)
New Jersey (2911)
New Mexico (32)
New York (2842)
North Carolina (1514)
North Dakota (10)
Northern California (4971)
Ohio (319)
Oklahoma (22)
Oregon (52)
Pennsylvania (2161)
Puerto Rico (20)
Rhode Island (47)
South America (1452)
South Carolina (60)
South Dakota (1)
Southern California (4080)
Tennessee (164)
Texas (1658)
United States (38580)
Utah (319)
Vermont (1)
Virginia (269)
Washington D.C. (84)
Washington State (896)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
818,218 Results for "purdue pharma l p research and development new jersey".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Layoffs
BMS Continues New Jersey Layoffs, Bringing Yearly Total to Nearly 900
BMS is letting go of 68 employees in Lawrenceville, New Jersey. The pharma has now cut over 1,000 employees there since April 2024 as part of its cost-cutting measures.
June 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Tanabe Pharma America to Present Preclinical Research at MNDA on Edaravone’s Potential Mechanisms in ALS
December 5, 2025
·
2 min read
Job Trends
9 Companies Hiring in New Jersey
Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.
June 12, 2025
·
1 min read
·
Chantal Dresner
Press Releases
IGC Pharma Adds Ichor Research as New Site for CALMA Phase 2 Alzheimer’s Trial
September 30, 2025
·
3 min read
Press Releases
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
November 14, 2025
·
5 min read
Mergers & acquisitions
5 SMID-Cap Pharmas Poised for M&A Action
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
October 29, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation
November 28, 2025
·
4 min read
Press Releases
Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
October 21, 2025
·
9 min read
1 of 81,822
Next
